Departments of Radiology.
Urology, and.
Invest Radiol. 2019 Feb;54(2):118-128. doi: 10.1097/RLI.0000000000000515.
The aims of this study were to identify higher-grade clear cell renal cell carcinoma (cRCC) with native T1 mapping and to histologically correlate the results with the collagen volume fraction.
For this institutional review board-approved, single-center prospective study, 68 consecutive patients received abdominal magnetic resonance imaging scans at 1.5 T between January 2017 and July 2018, using a Modified Look-Locker Inversion Recovery (MOLLI) sequence. Thirty patients with cRCC (20 men; mean age, 61.9 ± 13.1 years) who underwent partial or radical nephrectomy and histological grading according to the International Society of Urological Pathology (ISUP) classification and a separate healthy cohort of 30 individuals without renal malignancies or complex cysts (16 men; mean age, 59.7 ± 14.6 years) met the eligibility criteria. T1 values were quantitatively measured with region of interest measurements in T1 maps. Quantification of the collagen volume fraction was performed on histological sections (picrosirius red staining).
Native T1 values were significantly lower for lower-grade cRCC (ISUP 1 and 2) compared with higher-grade cRCC (ISUP 3 and 4; P < 0.001). A cutoff value of 1101 milliseconds distinguished higher-grade from lower-grade tumors with a sensitivity of 100% (95% confidence interval [CI], 0.69-1.00), a specificity of 85% (95% CI, 0.62-0.97), and an accuracy of 90% (95% CI, 0.73-0.98). Native T1 values were significantly associated with the histological collagen volume fraction (P < 0.05). Furthermore, T1 times in the renal cortex, medulla, and tumor tissue showed an excellent interobserver agreement.
Native T1 mapping could represent an in vivo biomarker for the differentiation of lower- and higher-grade cRCCs, providing incremental diagnostic value beyond qualitative magnetic resonance imaging features.
本研究旨在利用 T1 mapping 识别高级别透明细胞肾细胞癌(cRCC),并与胶原容积分数进行组织学相关性分析。
本研究为机构审查委员会批准的单中心前瞻性研究,纳入 2017 年 1 月至 2018 年 7 月期间在 1.5T 磁共振扫描仪上接受腹部磁共振成像检查的 68 例连续患者,采用改良 Look-Locker 反转恢复(MOLLI)序列。符合纳入标准的患者包括 30 例接受部分或根治性肾切除术且根据国际泌尿病理学会(ISUP)分级标准进行组织学分级的 cRCC 患者(20 例男性,平均年龄 61.9 ± 13.1 岁)和 30 例无肾恶性肿瘤或复杂囊肿的健康个体(16 例男性,平均年龄 59.7 ± 14.6 岁)。使用感兴趣区测量法在 T1 图谱中定量测量 T1 值。在组织学切片(苦味酸红染色)上进行胶原容积分数的定量分析。
低级别 cRCC(ISUP 1 和 2)的 T1 值明显低于高级别 cRCC(ISUP 3 和 4;P < 0.001)。当截断值为 1101 毫秒时,高级别肿瘤与低级别肿瘤的 T1 值有 100%的敏感性(95%置信区间[CI],0.69-1.00)、85%的特异性(95%CI,0.62-0.97)和 90%的准确性(95%CI,0.73-0.98)。T1 值与组织学胶原容积分数显著相关(P < 0.05)。此外,皮质、髓质和肿瘤组织的 T1 时间具有极好的观察者间一致性。
T1 映射可作为区分低级别和高级别透明细胞肾细胞癌的体内生物标志物,提供定性磁共振成像特征之外的附加诊断价值。